Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

  • Technology appraisal guidance
  • TA261
  • Published: 
Download guidance (PDF)

6 Recommendations for further research

6.1 Further research on the clinical effectiveness of rivaroxaban compared with LMWH in patients with active cancer should be conducted.